Protecting Life and Limb in Peripheral Artery Disease

Affiliations

Editorial

Mark A Creager. Circulation. 2018.

. 2018 Jan 23;137(4):351-353.

doi: 10.1161/CIRCULATIONAHA.117.032422.

¹ Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH. mark.a.creager@hitchcock.org.

No abstract available

Keywords: Editorials; peripheral artery disease.

Comment on

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Bonaca MP, et al. Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13. Circulation. 2018. PMID: 29133605 Clinical Trial.